3-环己基-3-氧代丙酸乙酯 | 15971-92-3

• 物质功能分类: 化学试剂 - 有机试剂 - 酯类
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 酮酸及其衍生物
• 中文名称: 3-环己基-3-氧代丙酸乙酯
• 英文名称: ethyl 3-cyclohexyl-3-oxopropanoate
• 英文别名: 3-cyclohexyl-3-oxo-propanoate
• CAS: 15971-92-3
• 化学式: C₁₁H₁₈O₃
• 分子量: 198.262
• InChiKey: ASYASKBLHYSMEG-UHFFFAOYSA-N

物化性质

• 沸点：
  165°C/20mmHg(lit.)
• 密度：
  1.039±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.82
• 拓扑面积：
  43.4
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2918300090
• WGK Germany：
  3
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  室温且干燥环境下使用。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Ethyl 3-cyclohexyl-3-oxopropanoate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Ethyl 3-cyclohexyl-3-oxopropanoate
CAS number: 15971-92-3

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C11H18O3
Molecular weight: 198.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-环己基-3-氧代丙酸乙酯 在 lithium aluminium tetrahydride 、 sodium hydroxide 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 1.0h， 生成 1-环己基-1,3-丙二醇
  参考文献：
  名称：

  WO2007/58852

  摘要：

  公开号：
• 作为产物：
  描述：

  3-氧代-4-戊酸乙酯 在 Lindlar's catalyst 氢气 、 对苯二酚 作用下， 以 甲醇 、 苯 为溶剂， 生成 3-环己基-3-氧代丙酸乙酯
  参考文献：
  名称：

  Kugatova-Shemyakina,G.P. et al., Journal of Organic Chemistry USSR (English Translation), 1967, vol. 3, p. 1175 - 1180

  摘要：

  DOI：

文献信息

• Synthesis and biological activity of new HMG-CoA reductase inhibitors. 1. Lactones of pyridine- and pyrimidine-substituted 3,5-dihydroxy-6-heptenoic (-heptanoic) acids
  作者：G. Beck、K. Kesseler、E. Baader、W. Bartmann、A. Bergmann、E. Granzer、H. Jendralla、B. Von Kerekjarto、R. Krause

  DOI：10.1021/jm00163a010

  日期：1990.1

  Lactones of pyridine- and pyrimidine-substituted 3,5-dihydroxy-6-heptenoic (-heptanoic) acids 2-4 have been synthesized. Extensive exploration of structure-activity relationships led to several compounds exceeding the inhibitory activity of mevinolin (1b) on HMG-CoA reductase, both in vitro and in vivo. First clinical trials with 2i (HR 780) are in preparation.

  已经合成了吡啶和嘧啶取代的3，5-二羟基-6-庚酸（-庚酸）2-4的内酯。广泛的结构-活性关系的探索导致在体外和体内，几种化合物都超过了美维诺林（1b）对HMG-CoA还原酶的抑制活性。2i（HR 780）的首次临床试验正在准备中。
• A simple base-mediated synthesis of diverse functionalized ring-fluorinated 4H-pyrans via double direct C–F substitutions
  作者：Jieru Yang、Ao Mao、Zhenting Yue、Wenxuan Zhu、Xuewei Luo、Chuwei Zhu、Yuanjing Xiao、Junliang Zhang

  DOI：10.1039/c5cc02073e

  日期：——

  A simple base-mediated synthesis of diverse substituted ring-fluorinated 4H-pyrans (monofluorinated 4H-pyrans) from trifluoromethylated alkenes and 1,3-dicarbonyl compounds was developed.

  一种简单的基础介导合成方法，可以从三氟甲基化烯烃和1,3-二羰基化合物合成多样取代的环氟代的4H-吡喃（单氟代的4H-吡喃）。
• Rh(<scp>iii</scp>)-catalyzed relay carbenoid functionalization of aromatic C–H bonds: access to π-conjugated fused heteroarenes
  作者：Ying Xie、Xun Chen、Xin Liu、Shi-Jian Su、Jianzhang Li、Wei Zeng

  DOI：10.1039/c6cc00254d

  日期：——

  A novel Rh(iii)-catalyzed relay cross-coupling cascade between arylketoimines and diazoesters is described. This transformation provides a concise access to unique π-conjugated 1-azaphenalenes (1-APLEs) via a double aryl Csp²–H bond carbenoid functionalization process.

  描述了一种新颖的Rh（III）催化的芳基酮亚胺和重氮酯之间的继发交叉偶联级联反应。该转化通过双芳基Csp2-H键卡宾功能化过程提供了一种简洁访问独特的π共轭1-氮杂苯并（1-APLEs）。
• [EN] HEPATITIS B CAPSID ASSEMBLY MODULATORS<br/>[FR] MODULATEURS D'ASSEMBLAGE DE CAPSIDE DE L'HÉPATITE B
  申请人：VENATORX PHARMACEUTICALS INC

  公开号：WO2021119081A1

  公开（公告）日：2021-06-17

  Described herein are hepatitis B capsid assembly modulators and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of hepatitis B.

  本文描述了乙型肝炎壳蛋白组装调节剂和包含该类化合物的药物组合物。这些化合物和组合物对于治疗乙型肝炎是有用的。
• [EN] 3-SUBSTITUTED 2-AMINO-INDOLE DERIVATIVES<br/>[FR] DÉRIVÉS DE 2-AMINO-INDOLE 3-SUBSTITUÉS
  申请人：TAKEDA PHARMACEUTICAL

  公开号：WO2015198045A1

  公开（公告）日：2015-12-30

  The present invention provides compounds of formula (I) (Formula (I)) and pharmaceutically acceptable salts thereof, wherein Q, X% X4,X5 X6, X7,R1, R2, R3 and R8 are as defined in the specification, processes for the preparation of such compounds, pharmaceutical compositions containing them and the use of such compounds in therapy.

  本发明提供了公式(I)（公式(I)）的化合物及其药用可接受的盐，其中Q，X，X4，X5，X6，X7，R1，R2，R3和R8如说明书中所定义，这些化合物的制备方法，包含它们的药物组合物以及这些化合物在治疗中的用途。